The University of Queensland

Journal Article

• Targeting potential of innate lymphoid cells in melanoma and other cancers

  Seo, Hobin, Verma, Amisha, Kinzel, Megan, Huang, Qiutong, Mahoney, Douglas J. and Jacquelot, Nicolas (2023). Targeting potential of innate lymphoid cells in melanoma and other cancers. Pharmaceutics, 15 (7) 2001, 1-21. doi: 10.3390/pharmaceutics15072001

• A protocol to isolate bone marrow innate lymphoid cells for alymphoid mouse reconstitution

  Jacquelot, Nicolas, Huang, Qiutong, Belz, Gabrielle T. and Seillet, Cyril (2022). A protocol to isolate bone marrow innate lymphoid cells for alymphoid mouse reconstitution. STAR Protocols, 3 (3) 101534, 1-19. doi: 10.1016/j.xpro.2022.101534

• Type 2 innate lymphoid cells protect against colorectal cancer progression and predict improved patient survival

  Huang, Qiutong, Jacquelot, Nicolas, Preaudet, Adele, Hediyeh-zadeh, Soroor, Souza-Fonseca-Guimaraes, Fernando, McKenzie, Andrew N. J., Hansbro, Philip M., Davis, Melissa J., Mielke, Lisa A., Putoczki, Tracy L. and Belz, Gabrielle T. (2021). Type 2 innate lymphoid cells protect against colorectal cancer progression and predict improved patient survival. Cancers, 13 (3) 559, 559-16. doi: 10.3390/cancers13030559

• Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma

  Jacquelot, Nicolas, Seillet, Cyril, Wang, Minyu, Pizzolla, Angela, Liao, Yang, Hediyeh-zadeh, Soroor, Grisaru-Tal, Sharon, Louis, Cynthia, Huang, Qiutong, Schreuder, Jaring, Souza-Fonseca-Guimaraes, Fernando, de Graaf, Carolyn A., Thia, Kevin, Macdonald, Sean, Camilleri, Mary, Luong, Kylie, Zhang, Shengbo, Chopin, Michael, Molden-Hauer, Tristan, Nutt, Stephen L., Umansky, Viktor, Ciric, Bogoljub, Groom, Joanna R., Foster, Paul S., Hansbro, Philip M., McKenzie, Andrew N. J., Gray, Daniel H. D., Behren, Andreas, Cebon, Jonathan ... Belz, Gabrielle T. (2021). Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma. Nature Immunology, 22 (7), 851-864. doi: 10.1038/s41590-021-00943-z

• TCF-1 limits the formation of Tc17 cells via repression of the MAF–RORγt axis

  Mielke, Lisa A., Liao, Yang, Clemens, Ella Bridie, Firth, Matthew A., Duckworth, Brigette, Huang, Qiutong, Almeida, Francisca F., Chopin, Michael, Koay, Hui-Fern, Bell, Carolyn A., Hediyeh-Zadeh, Soroor, Park, Simone L., Raghu, Dinesh, Choi, Jarny, Putoczki, Tracy L., Hodgkin, Philip D., Franks, Ashley E., Mackay, Laura K., Godfrey, Dale I., Davis, Melissa J., Xue, Hai-Hui, Bryant, Vanessa L., Kedzierska, Katherine, Shi, Wei and Belz, Gabrielle T. (2019). TCF-1 limits the formation of Tc17 cells via repression of the MAF–RORγt axis. Journal of Experimental Medicine, 216 (7), 1682-1699. doi: 10.1084/jem.20181778

• Acute myeloid leukemia requires Hhex to enable PRC2-mediated epigenetic repression of Cdkn2a

  Shields, Benjamin J., Jackson, Jacob T., Metcalf, Donald, Shi, Wei, Huang, Qiutong, Garnham, Alexandra L., Glaser, Stefan P., Beck, Dominik, Pimanda, John E., Bogue, Clifford W., Smyth, Gordon K., Alexander, Warren S. and McCormack, Matthew P. (2016). Acute myeloid leukemia requires Hhex to enable PRC2-mediated epigenetic repression of Cdkn2a. Genes and Development, 30 (1), 78-91. doi: 10.1101/gad.268425.115